FDA Inspection 1123300 — Nartex Laboratorios Homeopaticos S.A. de C.V.
The FDA completed an inspection of Nartex Laboratorios Homeopaticos S.A. de C.V. on February 28, 2020 in Torreon. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 28, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Torreon (Mexico)